abstract |
The present invention relates to a peptide compound Lys-Ile-Cys-Ile as a therapeutic agent for the prevention and / or treatment of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, cardiovascular diseases and metabolic diseases. And to the use of -Arg-Ile-Gln-Ile-Ser-OH. In addition, the present invention optionally comprises a peptide Lys-Ile-Cys-Ile-Arg-Ile-Gln-Ile-Ser-, in combination with at least one pharmaceutically acceptable carrier, antifreeze, lyophilizer, excipient and / or diluent. It relates to a pharmaceutical composition containing OH, preferably in the form of a lyophilizate or liquid buffer or artificial breast milk preparation or breast milk substitute. |